Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gemcitabine × CNS × Clear all

Phase

Status

Completed 7 Active not recruiting 3 Unknown 2 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 111 Genitourinary 40 Head & Neck 25 Lymphoid 23 Thoracic 22 Breast 18 Sarcoma 13 Gynecologic 12 Tumor-Agnostic 7 Other solid neoplasm 5 Other hematologic neoplasm 2 Dermatologic 2 Other neoplasm 1 CNS 1

Conditions

Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 61 Magnetic Resonance Spectroscopy 56 Specimen Handling 36 Radiotherapy 35 Radiosurgery 30 Cyclophosphamide 22 Bevacizumab 22 pembrolizumab 19 Radiation 14 Blood Specimen Collection 14 fludarabine 12 Irinotecan 12 Pemetrexed 11 Lomustine 11 Nivolumab 10 Etoposide 10 Carboplatin 10 Biopsy 10 Vincristine 9 trametinib 8 lutetium Lu 177 dotatate 8 Surgical Procedures, Operative 8 Fluorodeoxyglucose F18 8 naxitamab 7 fluciclovine F-18 7 Everolimus 7 Drug Therapy 7 olaparib 6 gallium Ga 68 dotatate 6 dinutuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡